The novel therapy of the medication represents a significant advance in the care of diabetes mellitus type 2. Different to existing drugs, tirzepatide impacts two pathways – the GLP-1 hormone and GIP – resulting in https://tirzepatidepeptide501055.blogpixi.com/42359568/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment